HSBC Holdings’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $74M | Buy |
1,544,018
+1,486,020
| +2,562% | +$65.1M | 0.04% | 403 |
|
|
2025
Q4 | $2.25M | Sell |
57,998
-181,710
| -76% | -$6.93M | ﹤0.01% | 1518 |
|
|
2025
Q3 | $8.45M | Buy |
239,708
+203,408
| +560% | +$7.36M | 0.01% | 992 |
|
|
2025
Q2 | $1.3M | Sell |
36,300
-77,498
| -68% | -$2.57M | ﹤0.01% | 1670 |
|
|
2025
Q1 | $3.5M | Sell |
113,798
-58,518
| -34% | -$1.85M | ﹤0.01% | 1238 |
|
|
2024
Q4 | $4.38M | Sell |
172,316
-30,304
| -15% | -$804K | ﹤0.01% | 1184 |
|
|
2024
Q3 | $5.69M | Sell |
202,620
-322,194
| -61% | -$8.92M | ﹤0.01% | 1081 |
|
|
2024
Q2 | $13.8M | Sell |
524,814
-399,619
| -43% | -$11.1M | 0.01% | 773 |
|
|
2024
Q1 | $28.1M | Buy |
924,433
+779,163
| +536% | +$23M | 0.02% | 607 |
|
|
2023
Q4 | $4.06M | Buy |
145,270
+10,893
| +8% | +$299K | ﹤0.01% | 1230 |
|
|
2023
Q3 | $3.63M | Buy |
134,377
+1,682
| +1% | +$50K | ﹤0.01% | 1203 |
|
|
2023
Q2 | $4.07M | Buy |
132,695
+107,591
| +429% | +$3.64M | ﹤0.01% | 1137 |
|
|
2023
Q1 | $906K | Sell |
25,104
-750,073
| -97% | -$27.8M | ﹤0.01% | 1805 |
|
|
2022
Q4 | $30.3M | Buy |
775,177
+308,651
| +66% | +$12.9M | 0.04% | 506 |
|
|
2022
Q3 | $18.9M | Buy |
466,526
+232,534
| +99% | +$9.93M | 0.03% | 568 |
|
|
2022
Q2 | $9.82M | Buy |
+233,992
| New | +$9.59M | 0.02% | 909 |
|
|
2021
Q4 | – | Sell |
-26,164
| Closed | -$956K | – | 3339 |
|
|
2021
Q3 | $956K | Buy |
26,164
+9,217
| +54% | +$358K | ﹤0.01% | 1909 |
|
|
2021
Q2 | $700K | Buy |
+16,947
| New | +$721K | ﹤0.01% | 1966 |
|
|
2021
Q1 | – | Sell |
-18,341
| Closed | -$899K | – | 3067 |
|
|
2020
Q4 | $899K | Buy |
18,341
+12,307
| +204% | +$522K | ﹤0.01% | 1769 |
|
|
2020
Q3 | $259K | Buy |
+6,034
| New | +$259K | ﹤0.01% | 2338 |
|
Other funds holding RPRX
